analysts and calls -- Morgan Stanley | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
analysts and calls -- Morgan Stanley

An SI Board Since September 2002

Posts	SubjectMarks	Bans
31	10	0

Emcee: scaram(o)uche	Type: Moderated

Introduction Compact

Who are the current biotech analysts at Morgan Stanley, and what are their calls?

In five years, this may be a resource. Please feel free to comment on their OLD calls at MS or other institutions.

I will occasionally update this subject post to (1) reflect the current team, or (2) point at guys/gals when they screw up, take their millions, and head for a hedge fund (etc.).

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
31	Millennium Pharmaceuticals upgraded Morgan Stanley sees Velcade drug's sales	Icebrg	-	8/22/2003
30	Morgan Stanley cuts specialty pharma Yet for the specialty pharmaceuticals grou	Icebrg	-	7/11/2003
29	MS do not like TELK? Or, maybe, they are just playing: *buy on rumor…sell on ne	Miljenko Zuanic	-	6/11/2003
28	On May 14, Morgan Stanley's analyst Steven Harr said the following about Mil	Icebrg	-	6/5/2003
27	To all, Harr is a big MDCO supporter and I think that bias colors his decision	JFitnich	-	5/16/2003
26	OSI's Shares Rise on Optimism Over Cancer Drug Thursday May 15, 2:59 pm ET B	Icebrg	-	5/15/2003
25	I suspect Harr's Velcade revenue assumptions are a) on the low end of the ra	tuck	-	5/14/2003
24	>>The time to make a call is after the deal and ASCO>> That's o	Icebrg	-	5/14/2003
23	The early approval changes things a bit, but perhaps Harr feels this is priced i	tuck	-	5/14/2003
22	Tuck He is at least consistent with his October call. And he should be. Nothing	Icebrg	-	5/14/2003
21	I have to wonder what assumptions MS is making here. The burn would change sign	tuck	-	5/14/2003
20	3:04 pm Millennium Pharm reiterated Underweight at Morgan Stanley (MLNM) 14.29 +	Icebrg	-	5/14/2003
19	Medi from overweight to equalweight, on valuation. Be interesting to see if thi	keokalani'nui	-	3/17/2003
18	doesn't mean much, just putting it here because I've got it at the momen	scaram(o)uche	-	12/6/2002
17	The reason that I looked?? Morgan Stanley has frequently been on the ask for VP	scaram(o)uche	-	12/6/2002
16	stockselector.com Caroline Copithorne Morgan Stanley Last Report Date Com	scaram(o)uche	-	12/6/2002
15	>> Sheesh. Not much patience out there. << It closed at $5.15 on th	scaram(o)uche	-	10/23/2002
14	OT - Comment: Well, it looks like the market might be able to get a little exci	Harold Engstrom	-	10/22/2002
13	11/03/00...... hairlosssucks.com <i>The robust spending mixed with disco	scaram(o)uche	-	10/16/2002
12	Harr was previously at Robbie Stephens....... 11/19/00........ thestreet.com	scaram(o)uche	-	10/16/2002
11	I won't take exception with Harr. However, it would be interesting to read	scaram(o)uche	-	10/16/2002
10	RESEARCH ALERT-Millenium started as underweight Wednesday October 16, 11:58 am E	Icebrg	-	10/16/2002
9	oooch oooooch ouch ouch. (eom)	scaram(o)uche	-	10/3/2002
8	Not necessarily MS, but all analysts. Check out who checked in at number 5 as r	keokalani'nui	-	10/3/2002
7	Ah, OK. So MS is going to try to integrate some universal call, "market ne	scaram(o)uche	-	10/2/2002

Go to reply# or date (mm/dd/yy):